BC Partners to exit majority stake in Aenova to Kuhne Holding

Aenova Group is a pharma contract development and manufacturing organisation.

  • BC Partners acquired Aenova in 2012
  • Aenova is based in Munich
  • BC Partners is an investment firm with over €40bn in assets

BC Partners has agreed to sell Aenova Group, a pharma contract development and manufacturing organisation (CDMO), to Kühne Holding.

BC Partners will reinvest alongside Kühne Holding and will remain as a minority shareholder.

Share this